147 related articles for article (PubMed ID: 15518750)
1. Clinical experience of mycophenolate mofetil in the treatment of chronic allograft nephropathy in kidney transplantation: three-year follow-up.
Chu SH; Wu CT; Chou CC; Chen Y; Liu KL; Chiang YJ
Transplant Proc; 2004 Sep; 36(7):2073-5. PubMed ID: 15518750
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil reduces deterioration of renal function in patients with chronic allograft nephropathy. A follow-up study by the Spanish Cooperative Study Group of Chronic Allograft Nephropathy.
Gonzalez Molina M; Seron D; Garcia del Moral R; Carrera M; Sola E; Jesus Alferez M; Gomez Ullate P; Capdevila L; Gentil MA
Transplantation; 2004 Jan; 77(2):215-20. PubMed ID: 14742984
[TBL] [Abstract][Full Text] [Related]
3. Chronic renal allograft rejection: no response to mycophenolate mofetil.
Glicklich D; Gupta B; Schurter-Frey G; Greenstein SM; Schechner RS; Tellis VA
Transplantation; 1998 Aug; 66(3):398-9. PubMed ID: 9721811
[TBL] [Abstract][Full Text] [Related]
4. Low-dose mycophenolate mofetil is an effective and safe treatment to permit phased reduction in calcineurin inhibitors in chronic allograft nephropathy.
Afzali B; Shah S; Chowdhury P; O'sullivan H; Taylor J; Goldsmith D
Transplantation; 2005 Feb; 79(3):304-9. PubMed ID: 15699760
[TBL] [Abstract][Full Text] [Related]
5. Conversion from cyclosporine-based immunosuppression to tacrolimus/mycophenolate mofetil in patients with refractory and ongoing acute renal allograft rejection.
Boratyńska M; Banasik M; Patrzałek D; Klinger M
Ann Transplant; 2006; 11(2):51-6. PubMed ID: 17494290
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up.
Ducloux D; Motte G; Billerey C; Bresson-Vautrin C; Vautrin P; Rebibou JM; Saint-Hillier Y; Chalopin JM
Transpl Int; 2002 Sep; 15(8):387-92. PubMed ID: 12221456
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil dose reduction in renal transplant recipients: a 5-year follow-up study.
Khosroshahi HT; Shoja MM; Peyrovifar A; Hashemi SR; Amjadi M
Transplant Proc; 2009 Sep; 41(7):2797-9. PubMed ID: 19765438
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of pediatric transplant recipients: mycophenolic acid trough levels are not a good indicator for long-term graft function.
Pape L; Ehrich JH; Offner G
Clin Transplant; 2004 Oct; 18(5):576-9. PubMed ID: 15344963
[TBL] [Abstract][Full Text] [Related]
9. Selective use of mycophenolate mofetil in renal transplant patients in Indian scenario.
Srivastava A; Singh V; Kumar A; Sharma RK; Gupta A
Transplant Proc; 2004 Sep; 36(7):2060-4. PubMed ID: 15518746
[TBL] [Abstract][Full Text] [Related]
10. Effect of mycophenolate mofetil on kidney graft function and body weight in patients with chronic allograft nephropathy.
Grebe SO; Mueller TF; Troeltsch M; Ebel H; Lange H
Transplant Proc; 2004 Dec; 36(10):2974-8. PubMed ID: 15686673
[TBL] [Abstract][Full Text] [Related]
11. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M
Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
[TBL] [Abstract][Full Text] [Related]
12. Conversion from mycophenolate mofetil to azathioprine in high-risk renal allograft recipients on cyclosporine-based immunosuppression.
Lou HX; Vathsala A
Transplant Proc; 2004 Sep; 36(7):2090-1. PubMed ID: 15518756
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil substitution for cyclosporine a in renal transplant recipients with chronic progressive allograft dysfunction: the "creeping creatinine" study.
Dudley C; Pohanka E; Riad H; Dedochova J; Wijngaard P; Sutter C; Silva HT;
Transplantation; 2005 Feb; 79(4):466-75. PubMed ID: 15729174
[TBL] [Abstract][Full Text] [Related]
14. Treatment of chronic rejection in renal transplantation by mycophenolate mofetil (MMF): a preliminary report of six-month experience.
Jirasiritham S; Sumethkul V; Mavichak V; Jirasiritham S; Chiewsilp P; Leenanupunth C; Kochakarn W
Transplant Proc; 1998 Nov; 30(7):3576-7. PubMed ID: 9838566
[No Abstract] [Full Text] [Related]
15. Comparison of transplanted kidney function in patients on two different doses of mycophenolate mofetil.
Khosroshahi HT; Nahali A; Gojazadeh M; Shoja MM
Transplant Proc; 2006 Sep; 38(7):2035-7. PubMed ID: 16979991
[TBL] [Abstract][Full Text] [Related]
16. Effect of adding Mycophenolate mofetil in paediatric renal transplant recipients with chronical cyclosporine nephrotoxicity.
Filler G; Gellermann J; Zimmering M; Mai I
Transpl Int; 2000; 13(3):201-6. PubMed ID: 10935703
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study.
Abramowicz D; Del Carmen Rial M; Vitko S; del Castillo D; Manas D; Lao M; Gafner N; Wijngaard P;
J Am Soc Nephrol; 2005 Jul; 16(7):2234-40. PubMed ID: 15917338
[TBL] [Abstract][Full Text] [Related]
19. Conversion of azathioprine to mycophenolate mofetil and chronic graft failure progression.
Lezaic VD; Marinkovic J; Ristic S; Dokic ZM; Basta Jovanovic G; Radivojevic DM; Blagojevic RN; Djukanovic LD
Transplant Proc; 2005 Mar; 37(2):734-6. PubMed ID: 15848517
[TBL] [Abstract][Full Text] [Related]
20. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.
Kato Y; Tojimbara T; Iwadoh K; Koyama I; Nanmoku K; Kai K; Sannomiya A; Nakajima I; Fuchinoue S; Teraoka S
Int Immunopharmacol; 2006 Dec; 6(13-14):1984-92. PubMed ID: 17161352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
